SOD1 can accumulate within stress granules via LLPS.343 In a clinical trial involving 50 ALS patients with SOD1 mutations, CSF SOD1 concentrations decreased following 12 weeks of intrathecal administration of the antisense oligonucleotide tofersen at the highest dose.344. Here, SOD1 is linked to amyotrophic lateral sclerosis.